financetom
Business
financetom
/
Business
/
BRIEF-Bansk Group To Acquire A Majority Stake In Skincare Brand Byoma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Bansk Group To Acquire A Majority Stake In Skincare Brand Byoma
Sep 9, 2025 10:40 AM

Sept 9 (Reuters) - BANSK GROUP:

* BANSK GROUP TO ACQUIRE A MAJORITY STAKE IN SKINCARE BRAND

BYOMA

* BANSK GROUP: TERMS OF TRANSACTION WERE NOT DISCLOSED

Source text:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Trump sues Wall Street Journal over Epstein report, seeks $10 billion
Trump sues Wall Street Journal over Epstein report, seeks $10 billion
Jul 18, 2025
* Trump denies WSJ report on Epstein birthday letter * U.S. wants Epstein grand jury transcripts made public * Trump supporters demand more Epstein documents * Dow Jones defends accuracy of its reporting (Adds Dow Jones statement, details about lawsuit and context of damages, paragraphs 2, 7-15) By Nandita Bose and Jonathan Stempel WASHINGTON/NEW YORK, July 18 (Reuters) - U.S....
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Jul 18, 2025
By Bhanvi Satija (Reuters) -U.S. regulators asked Sarepta Therapeutics ( SRPT ) on Friday to voluntarily halt shipments of its Elevidys gene therapy after a muscular dystrophy patient who received a different, experimental treatment died, but the company said it would not do so. The Food and Drug Administration announced the move, confirming an earlier Reuters report, after making the...
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys
Jul 18, 2025
By Bhanvi Satija (Reuters) -U.S. regulators asked Sarepta Therapeutics ( SRPT ) on Friday to voluntarily halt shipments of its Elevidys gene therapy after a muscular dystrophy patient who received a different, experimental treatment died, but the company said it would not do so. The Food and Drug Administration announced the move, confirming an earlier Reuters report, after making the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved